Site Members can sign up for company wide alerts
Lawsuit Overview
June 30, 2023 - An investor in shares of ImmunityBio, Inc. (NASDAQ: IBRX) filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by ImmunityBio, Inc. in connection with certain allegedly false and misleading statements made between May 23, 2022 and May 10, 2023. San Diego, CA based ImmunityBio, Inc., a clin...
You must register (for free) or login to view the entire case.